XML 60 R54.htm IDEA: XBRL DOCUMENT v3.25.3
Shareholders' Equity - Additional Information (Details) - USD ($)
1 Months Ended 2 Months Ended 3 Months Ended 9 Months Ended
Jan. 27, 2025
Nov. 21, 2024
Feb. 06, 2024
Jan. 31, 2025
Feb. 29, 2024
Jan. 27, 2025
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Nov. 19, 2024
May 14, 2024
Mar. 31, 2024
Dec. 31, 2021
Subsidiary or Equity Method Investee [Line Items]                              
Preferred stock, shares authorized             2,000,000   2,000,000   2,000,000        
Preferred stock, shares issued             0   0   0        
Preferred stock, shares outstanding             0   0   0        
Common stock, shares authorized             450,000,000   450,000,000   450,000,000        
Shares issued through registered direct financings, shares           39,473,688                  
Common stock, shares issued             230,327,537   230,327,537   220,416,326        
Common stock, shares outstanding             230,327,537   230,327,537   220,416,326        
Warrants and rights expiry date             May 21, 2028   May 21, 2028            
Fair value of warrant liabilities             $ 45,171,000   $ 45,171,000   $ 6,161,000        
Combined purchase price of common stock and warrants                       $ 0.76      
Class of warrant or right, number                       39,473,688      
Broadwood Partners, L.P [Member]                              
Subsidiary or Equity Method Investee [Line Items]                              
Shares issued through registered direct financings, shares 7,894,737                            
Proceeds from sale of common shares with warrants $ 6,000,000                            
Stock issuance costs 600,000                            
Fair value of warrant liabilities $ 2,100,000         $ 2,100,000                  
Sale of stock       7,894,737 6,730,770                    
Class of warrant or right, number 7,894,737     7,894,737   7,894,737                  
H.C. Wainwright & Co., LLC [Member]                              
Subsidiary or Equity Method Investee [Line Items]                              
Aggregate cash fee percentage   7.00%                          
Percentage of management fee of aggregate gross proceeds   1.00%                          
Class of warrant or right, number 1,973,684         1,973,684                  
Exercise price per share             $ 0.95   $ 0.95            
H.C. Wainwright & Co., LLC [Member] | First tranche [Member]                              
Subsidiary or Equity Method Investee [Line Items]                              
Fair value of warrant liabilities   $ 400,000                          
H.C. Wainwright & Co., LLC [Member] | Second Tranche [Member]                              
Subsidiary or Equity Method Investee [Line Items]                              
Fair value of warrant liabilities $ 100,000         $ 100,000                  
February 2024 Registered Direct Offering | Parent Company [Member]                              
Subsidiary or Equity Method Investee [Line Items]                              
Proceeds from sale of common shares with warrants     $ 14,000,000                        
Stock issuance costs     $ 100,000                        
Sale of stock     13,461,540                        
Sale of Stock, Price Per Share     $ 1.04                        
Prior Sales Agreement [Member] | Parent Company [Member]                              
Subsidiary or Equity Method Investee [Line Items]                              
Net proceeds                             $ 64,100,000
ATM Sales Agreement [Member] | B. Riley Securities, Inc. [Member]                              
Subsidiary or Equity Method Investee [Line Items]                              
Percentage of commission payable                 3.00%            
ATM Sales Agreement [Member] | Parent Company [Member]                              
Subsidiary or Equity Method Investee [Line Items]                              
Weighted average price per share issuance of common stock             $ 1.32   $ 1.32 $ 1.26          
Net proceeds                         $ 39,970,000 $ 40,000,000  
Sale of stock             1,000,000 0 1,000,000 56,000          
Gross proceeds from issuance of common stock             $ 1,300,000   $ 1,300,000 $ 70,000          
Equity securities available for sale             $ 38,700,000   $ 38,700,000            
First Tranche [Member]                              
Subsidiary or Equity Method Investee [Line Items]                              
Shares issued through registered direct financings, shares   31,578,951                          
Warrants and rights expiry date   May 21, 2028                          
Proceeds from sale of common shares with warrants   $ 24,000,000                          
Stock issuance costs   2,300,000                          
Fair value of warrant liabilities   $ 7,900,000                          
Date of warrants exercisable   May 21, 2025                          
Class of warrant or right, number   31,578,951                          
Exercise price per share   $ 0.91